Philippe Astoul
- Solitary cystic mediastinal lymphangiomaBy Nataliya Khobta, Pascale Tomasini, Delphine Trousse, Fabien Maldonado, Pascal Chanez and Philippe AstoulNataliya Khobta*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USAPascale Tomasini*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USADelphine Trousse*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USAFabien Maldonado*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USAPascal Chanez*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USAPhilippe Astoul*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA*Dept of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, ¶Dept of Thoracic Surgery, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, §Dept of Ambulatory Platforms in Pneumology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, fDept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Assistance Publique - Hôpitaux de Marseille, Hôpital Nord, and #Aix-Marseille Université, Marseilles, France. +Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA
- Miliary mesothelioma: A consequence of trimodality therapy?By Lesek Purek, Sophie Laroumagne, Hervé Dutau and Philippe AstoulLesek PurekDivision of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord – Université de la Méditerranée, Marseille, FranceSophie LaroumagneDivision of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord – Université de la Méditerranée, Marseille, FranceHervé DutauDivision of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord – Université de la Méditerranée, Marseille, FrancePhilippe AstoulDivision of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord – Université de la Méditerranée, Marseille, France
- The feasibility of using a prospective multi-institutional database to measure outcomes from advanced bronchoscopyBy Julien Legodec, Bruno Escarguel, Philippe Astoul, Charles-Hugo Marquette and Jean-Michel VergnonJulien Legodec1Pulmonology, Sainte Anne Hospital, Toulon, France, MetropolitanBruno Escarguel1Pulmonology, Sainte Anne Hospital, Toulon, France, MetropolitanPhilippe Astoul1Pulmonology, Sainte Anne Hospital, Toulon, France, MetropolitanCharles-Hugo Marquette1Pulmonology, Sainte Anne Hospital, Toulon, France, MetropolitanJean-Michel Vergnon1Pulmonology, Sainte Anne Hospital, Toulon, France, Metropolitan
- F-18 FDG PET scan 20 years after talc pleurodesis: Report of 3 casesBy Thomas Vandemoortele, Sophie Laroumagne, Olivier Bylicki, Herve Dutau and Philippe AstoulThomas Vandemoortele1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FranceSophie Laroumagne1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FranceOlivier Bylicki1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FranceHerve Dutau1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FrancePhilippe Astoul1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, France
- Pleural atypical mesothelial hyperplasia: An early stage of pleural malignant mesothelioma?By Thomas Vandemoortele, Sophie Laroumagne, Olivier Bylicki, Sophie Giusiano, Hervé Dutau and Philippe AstoulThomas Vandemoortele1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FranceSophie Laroumagne1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FranceOlivier Bylicki1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FranceSophie Giusiano2Department of Pathology, Hôpital Nord, Marseille, FranceHervé Dutau1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FrancePhilippe Astoul1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, France
- Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesotheliomaBy Valentina Pinelli, Elisa Roca, Sophie Laroumagne, Silvia Lucchini, Gian Franco Tassi and Philippe AstoulValentina Pinelli1Pneumologia, Spedali Civili, Brescia, ItalyElisa Roca2Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North Hospital, University of The Mediterranean, Marseille, FranceSophie Laroumagne2Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North Hospital, University of The Mediterranean, Marseille, FranceSilvia Lucchini3Medicina Nucleare, Spedali Civili, Brescia, ItalyGian Franco Tassi1Pneumologia, Spedali Civili, Brescia, ItalyPhilippe Astoul2Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North Hospital, University of The Mediterranean, Marseille, France
- Incidence and management of anastomotic complications after bronchial resection: A retrospective studyBy Olivier Bylicki, Bastien Orsini, Sophie Laroumagne, Thomas Vandemoortele, Xavier D'Journo, Pascal-Alexandre Thomas, Philippe Astoul and Herve DutauOlivier Bylicki1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, France2Department of Pulmonary, Military Hopital Desgenettes, Lyon, FranceBastien Orsini3Department of Thoracic Surgery and Diseases of the Esophagus, Hopital Nord, University of the Mediterranean, Marseille, FranceSophie Laroumagne1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, FranceThomas Vandemoortele1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, FranceXavier D'Journo3Department of Thoracic Surgery and Diseases of the Esophagus, Hopital Nord, University of the Mediterranean, Marseille, FrancePascal-Alexandre Thomas3Department of Thoracic Surgery and Diseases of the Esophagus, Hopital Nord, University of the Mediterranean, Marseille, FrancePhilippe Astoul1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, FranceHerve Dutau1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, France
- Temporary endobronchial embolization with silicone spigots for moderate hemoptysis: A retrospective studyBy Olivier Bylicki, Sophie Laroumagne, Thomas Vandemoortele, Jean Michel Peloni, Philippe Astoul and Herve DutauOlivier Bylicki1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, France2Department of Pulmonary, Military Hopital Desgenettes, Lyon, FranceSophie Laroumagne1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, FranceThomas Vandemoortele1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, FranceJean Michel Peloni2Department of Pulmonary, Military Hopital Desgenettes, Lyon, FrancePhilippe Astoul1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, FranceHerve Dutau1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, University of the Mediterranean, Marseille, France
- EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practiceBy Thomas Vandemoortele, Isabelle Nanni-Metellus, Elise Kaspi, Véronique Secq, Sophie Laroumagne, Patrice Roll, Elisa Roca, Hervé Dutau, Andrée Robaglia and Philippe AstoulThomas Vandemoortele1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceIsabelle Nanni-Metellus2Biologic Oncology Transfer Laboratory, Medical Faculty, Marseille, FranceElise Kaspi3Cellular Biology Laboratory, Hôpital La Timone, Marseille, FranceVéronique Secq4Department of Anatomopathology Laboratory, Hôpital Nord, Marseille, FranceSophie Laroumagne1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FrancePatrice Roll3Cellular Biology Laboratory, Hôpital La Timone, Marseille, FranceElisa Roca1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceHervé Dutau1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceAndrée Robaglia3Cellular Biology Laboratory, Hôpital La Timone, Marseille, FrancePhilippe Astoul1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, France
- A new endoscopic standardized grading system for macroscopic central airway complications following lung transplantion: The MDS classificationBy Hervé Dutau, Thomas Vandemoortele, Sophe Laroumagne, Philippe Astoul, Pascal Thomas, Martine Reynaud-Gaubert and Jean-Michel VergnonHervé Dutau1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, FranceThomas Vandemoortele1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, FranceSophe Laroumagne1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, FrancePhilippe Astoul1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, FrancePascal Thomas1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, FranceMartine Reynaud-Gaubert1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, FranceJean-Michel Vergnon1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, France
- Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspirationBy Thomas Vandemoortele, Isabelle Nanni-Metellus, Elise Kaspi, Véronique Secq, Sophie Laroumagne, Patrice Roll, Elisa Roca, Hervé Dutau, Philippe Astoul and Andrée RobagliaThomas Vandemoortele1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceIsabelle Nanni-Metellus2Biologic Oncology Transfer Laboratory, Medical Faculty, Marseille, FranceElise Kaspi3Cellular Biology Laboratory, Hôpital La Timone, Marseille, FranceVéronique Secq4Department of Anatomopathology Laboratory, Hôpital Nord, Marseille, FranceSophie Laroumagne1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FrancePatrice Roll3Cellular Biology Laboratory, Hôpital La Timone, Marseille, FranceElisa Roca1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceHervé Dutau1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FrancePhilippe Astoul1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceAndrée Robaglia3Cellular Biology Laboratory, Hôpital La Timone, Marseille, France
- Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusionBy Jérôme Plojoux, Marios Froudarakis, Elise Kaspi, Sophie Laroumagne, Hervé Dutau and Philippe AstoulJérôme Plojoux1Division of Pulmonology, Department of Medical Specializations, Geneva University Hospital, Geneva, SwitzerlandMarios Froudarakis2Department of Pneumonology, Democritus University of Thrace Medical School, Alexandroupolis, GreeceElise Kaspi4Faculté de Pharmacie, Inserm UMR-S 1076, Marseille, FranceSophie Laroumagne3Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FranceHervé Dutau3Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, FrancePhilippe Astoul3Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, France
- CT scanner for the pleural staging of pleural cancer: How accurate is this?By Elisa Roca, Sophie Laroumagne, Stephanie Martinez, Hervé Dutau and Philippe AstoulElisa Roca1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceSophie Laroumagne1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceStephanie Martinez1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FranceHervé Dutau1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, FrancePhilippe Astoul1Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hôpital Nord, Marseille, France
- ERS task force statement: diagnosis and treatment of primary spontaneous pneumothoraxBy Jean-Marie Tschopp, Oliver Bintcliffe, Philippe Astoul, Emilio Canalis, Peter Driesen, Julius Janssen, Marc Krasnik, Nicholas Maskell, Paul Van Schil, Thomy Tonia, David A. Waller, Charles-Hugo Marquette and Giuseppe CardilloArticle | Published in 2015 in European Respiratory JournalJean-Marie Tschopp1Centre Valaisan de Pneumologie, Dept of Internal Medicine RSV, Montana, Switzerland13Task Force ChairsOliver Bintcliffe2Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UKPhilippe Astoul3Dept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hospital North Aix-Marseille University, Marseille, FranceEmilio Canalis4Dept of Surgery, University of Rovira I Virgili, Tarragona, SpainPeter Driesen5Dept of Pneumology, AZ Turnhout, Turnhout, BelgiumJulius Janssen6Dept of Pulmonary Diseases, Canisius Wilhelmina Hospital, Nijmegen, The NetherlandsMarc Krasnik7Dept of Cardiothoracic Surgery, Rigshospitalet, Copenhagen, DenmarkNicholas Maskell2Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UKPaul Van Schil8Dept of Thoracic and Vascular Surgery, Antwerp University Hospital, Antwerp, BelgiumThomy Tonia9Institute of Social and Preventative Medicine, University of Bern, Bern, SwitzerlandDavid A. Waller10Dept of Thoracic Surgery, Glenfield Hospital, Leicester, UKCharles-Hugo Marquette11Hospital Pasteur CHU Nice and Institute for Research on Cancer and Ageing, University of Nice Sophia Antipolis, Nice, FranceGiuseppe Cardillo12Dept of Thoracic Surgery, Carlo Forlanini Hospital, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy13Task Force Chairs
- ERS task force statement: diagnosis and treatment of primary spontaneous pneumothoraxBy Jean-Marie Tschopp, Oliver Bintcliffe, Philippe Astoul, Emilio Canalis, Peter Driesen, Julius Janssen, Marc Krasnik, Nicholas Maskell, Paul Van Schil, Thomy Tonia, David A. Waller, Charles-Hugo Marquette and Giuseppe CardilloJean-Marie Tschopp1Centre Valaisan de Pneumologie, Dept of Internal Medicine RSV, Montana, Switzerland13Task Force ChairsOliver Bintcliffe2Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UKPhilippe Astoul3Dept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hospital North Aix-Marseille University, Marseille, FranceEmilio Canalis4Dept of Surgery, University of Rovira I Virgili, Tarragona, SpainPeter Driesen5Dept of Pneumology, AZ Turnhout, Turnhout, BelgiumJulius Janssen6Dept of Pulmonary Diseases, Canisius Wilhelmina Hospital, Nijmegen, The NetherlandsMarc Krasnik7Dept of Cardiothoracic Surgery, Rigshospitalet, Copenhagen, DenmarkNicholas Maskell2Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UKPaul Van Schil8Dept of Thoracic and Vascular Surgery, Antwerp University Hospital, Antwerp, BelgiumThomy Tonia9Institute of Social and Preventative Medicine, University of Bern, Bern, SwitzerlandDavid A. Waller10Dept of Thoracic Surgery, Glenfield Hospital, Leicester, UKCharles-Hugo Marquette11Hospital Pasteur CHU Nice and Institute for Research on Cancer and Ageing, University of Nice Sophia Antipolis, Nice, FranceGiuseppe Cardillo12Dept of Thoracic Surgery, Carlo Forlanini Hospital, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy13Task Force Chairs
- Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusionsBy Elisa Roca, Romaric Lacroix, Coralie Judicone, Sophie Laroumagne, Stephane Robert, Sylvie Cointe, Alexandre Muller, Elise Kaspi, Patrice Roll, Alain Brisson, Claudio Tantucci, Philippe Astoul and Françoise Dignat-GeorgeElisa Roca1VRCM, UMR-S1076, Aix-Marseille University, Marseille, France2Division of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, APHM, Hôpital Nord, Marseille, France3Cattedra di Malattie dell'Apparato Respiratorio, Cattedra di Malattie dell'Apparato Respiratorio, Università degli Studi di Brescia, Brescia, ItalyRomaric Lacroix1VRCM, UMR-S1076, Aix-Marseille University, Marseille, France4Haematology and Vascular Biology Department, APHM, Hôpital de la Conception, Marseille, FranceCoralie Judicone5R and T Department, BioCytex, Marseille, FranceSophie Laroumagne2Division of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, APHM, Hôpital Nord, Marseille, FranceStephane Robert1VRCM, UMR-S1076, Aix-Marseille University, Marseille, FranceSylvie Cointe1VRCM, UMR-S1076, Aix-Marseille University, Marseille, France4Haematology and Vascular Biology Department, APHM, Hôpital de la Conception, Marseille, FranceAlexandre Muller5R and T Department, BioCytex, Marseille, FranceElise Kaspi6Service de Biologie Cellulaire, APHM, Hôpital de la Timone, Marseille, FrancePatrice Roll6Service de Biologie Cellulaire, APHM, Hôpital de la Timone, Marseille, FranceAlain Brisson7UMR-CBMN, University of Bordeaux-CNRS-IPB, Bordeaux, FranceClaudio Tantucci3Cattedra di Malattie dell'Apparato Respiratorio, Cattedra di Malattie dell'Apparato Respiratorio, Università degli Studi di Brescia, Brescia, ItalyPhilippe Astoul2Division of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, APHM, Hôpital Nord, Marseille, FranceFrançoise Dignat-George1VRCM, UMR-S1076, Aix-Marseille University, Marseille, France
- The place of airway stenting in the medico-surgical management of iatrogenic tracheal injuries: A 10 years retrospective analysisBy Rachid Tazi-Mezalek, Sophie Laroumagne, Philippe Astoul, Pascal Thomas and Hervé DutauRachid Tazi-Mezalek1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology Department, North University Hospital, Marseille, FranceSophie Laroumagne1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology Department, North University Hospital, Marseille, FrancePhilippe Astoul1Thoracic Oncology, Pleural Diseases and Interventional Pulmonology Department, North University Hospital, Marseille, FrancePascal Thomas2Department of Thoracic Surgery, North University Hospital, Marseille, FranceHervé Dutau2Department of Thoracic Surgery, North University Hospital, Marseille, France
- ERS Handbook of Respiratory Medicine
Edited by Paolo Palange and Gernot RohdeBook | Published in 2019DOI: 10.1183/9781849840798.erh01ISBN (electronic): 978-1-84984-079-8
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
